Medical Vaccine Supply – Hepatitis A/B Inactivated Vaccine

The contract secures the supply of FDA-approved inactivated Hepatitis A/B vaccine in pre-packaged form, fully compliant with National Drug Code standards and manufacturer specifications under CAGE code 0J8T0. All deliveries must adhere to federal medical supply chain requirements, ensuring product integrity, traceability, and proper handling throughout distribution. The vaccines are intended for use within the Department of Defense’s medical logistics network, with performance obligations aligned to the Defense Logistics Agency’s operational needs. Issued as a subcontract under NAICS code 325412 for pharmaceutical manufacturing, the agreement is administered by the Defense Logistics Agency and will support the federal healthcare supply chain. The contract was posted on July 20, 2026, and is linked to award document SPE2DX25D8022 with delivery identifier SPE2D926F7465, indicating it is part of an active procurement cycle. No set-aside provisions apply, and all terms are governed by federal acquisition standards for medical commodities.